WellSky Corp:企業の戦略的SWOT分析

◆英語タイトル:WellSky Corp - Strategic SWOT Analysis Review
◆商品コード:GDPH50880SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

WellSky Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

WellSky Corp (WellSky), formerly Mediware Information Systems Inc (Mediware), is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. The company provides software to healthcare and human service providers and payers. The company’s portfolio of solutions includes cellular therapy, medication management, human services, blood services, home care and home infusion reimbursement. WellSky’s portfolio of solutions is used in blood banks, pharmacies, home care centers, human service organizations, rehabilitation centers, respiratory therapy facilities, small hospitals and non-acute care organizations and cellular therapy. It also provides innovative software solutions for acute and non-acute care and community-based care. It is a subsidiary of TPG Capital. The company operates in the US and the Netherlands. WellSky is headquartered in Overland park, Kansas, the US.

WellSky Corp Key Recent Developments

Dec 01,2020: Post Acute Medical partners with WellSky to Envision the future of coordinated care across the continuum through technology, collaboration
Oct 22,2020: WellSky provides technology to support the American Red Cross’ Biotherapy Research, new therapeutics, and complex testing
Apr 28,2020: Wellsky, Qlik partner to deliver complimentary covid-19 tracking solution, empowering home-based care clients with data to better protect staff, allocate PPE
Apr 02,2020: WellSky advances better, smarter care with new initiatives, technology to support clients throughout covid-19 pandemic
Mar 27,2020: WellSky launches national care coordination network of 10,000 in-home care agencies to alleviate strains on heavily burdened hospitals

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
WellSky Corp – Key Facts
WellSky Corp – Key Employees
WellSky Corp – Key Employee Biographies
WellSky Corp – Major Products and Services
WellSky Corp – History
WellSky Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
WellSky Corp – Business Description
WellSky Corp – SWOT Analysis
SWOT Analysis – Overview
WellSky Corp – Strengths
WellSky Corp – Weaknesses
WellSky Corp – Opportunities
WellSky Corp – Threats
WellSky Corp – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
WellSky Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
WellSky Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
WellSky Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 01, 2020: Post Acute Medical partners with WellSky to Envision the future of coordinated care across the continuum through technology, collaboration
Oct 22, 2020: WellSky provides technology to support the American Red Cross’ Biotherapy Research, new therapeutics, and complex testing
Apr 28, 2020: Wellsky, Qlik partner to deliver complimentary covid-19 tracking solution, empowering home-based care clients with data to better protect staff, allocate PPE
Apr 02, 2020: WellSky advances better, smarter care with new initiatives, technology to support clients throughout covid-19 pandemic
Mar 27, 2020: WellSky launches national care coordination network of 10,000 in-home care agencies to alleviate strains on heavily burdened hospitals
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
WellSky Corp, Key Facts
WellSky Corp, Key Employees
WellSky Corp, Key Employee Biographies
WellSky Corp, Major Products and Services
WellSky Corp, History
WellSky Corp, Other Locations
WellSky Corp, Subsidiaries
WellSky Corp, Key Competitors
WellSky Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
WellSky Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
WellSky Corp, Recent Deals Summary

★海外企業調査レポート[WellSky Corp:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evine Live Inc.:企業の戦略・SWOT・財務分析
    Evine Live Inc. - Strategy, SWOT and Corporate Finance Report Summary Evine Live Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Samba Private Banking
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Clearwater Seafoods Incorporated (CLR):企業の財務・戦略的SWOT分析
    Clearwater Seafoods Incorporated (CLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Clementia Pharmaceuticals Inc (CMTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Clementia Pharmaceuticals Inc (Clementia) is a clinical stage biopharmaceutical company that focuses on the development of treatments for rare bone disorders and other diseases. Its lead product candidate Palovarotene is used for the treatment of fibrodysplasia ossificans progressiva (FOP), …
  • Taiyo Nippon Sanso Corp (4091):企業の財務・戦略的SWOT分析
    Taiyo Nippon Sanso Corp (4091) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Bank of Nova Scotia:企業のM&A・事業提携・投資動向
    The Bank of Nova Scotia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of Nova Scotia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bunzl plc (BNZL)-医療機器分野:企業M&A・提携分析
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company that supplies a broad range of non-food products to a diverse market sectors. The company offers an array of food packaging, disposable tableware and catering equipment, cleaning and hygiene supplies, guest amenities, persona …
  • Porsche Automobil Holding SE (PAH3):企業の財務・戦略的SWOT分析
    Porsche Automobil Holding SE (PAH3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Detour Gold Corp:企業の戦略・SWOT・財務分析
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Recipharm AB:企業のM&A・事業提携・投資動向
    Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Partners HealthCare System Inc-製薬・医療分野:企業M&A・提携分析
    Summary Partners HealthCare System Inc (PHS) is a nonprofit integrated health care organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other health care entitie …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Keio Corporation (9008):企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Mitsubishi Heavy Industries, Ltd.:戦略・SWOT・企業財務分析
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆